{
  "docId": "019de073-f22f-749b-aa66-140061a622d8",
  "docSlug": "bfa8f27558bcf20e1dab95d83263e96b",
  "documentTitle": "Berkeley Lights | Investor Day Presentation Deck | 91 slides",
  "authorId": "berkeley-lights",
  "authorName": "Berkeley Lights",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 52,
  "pageCount": 91,
  "prevPage": 51,
  "nextPage": 53,
  "slideType": "other",
  "function": "establish_context",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses a circular process diagram to illustrate the delivery of genetic material into a patient.",
  "elementsJson": null,
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019de073-f22f-749b-aa66-140061a622d8/52",
  "deckHref": "/decks/019de073-f22f-749b-aa66-140061a622d8",
  "deckJsonHref": "/decks/019de073-f22f-749b-aa66-140061a622d8.json",
  "deckAnchorHref": "/decks/019de073-f22f-749b-aa66-140061a622d8#slide-52",
  "components": [
    {
      "bbox": {
        "h": 0.8,
        "w": 0.45,
        "x": 0.5,
        "y": 0.1
      },
      "kind": "diagram",
      "text": "Circular process showing genetic material being packaged into a vector and injected into a patient to change DNA",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "688eeef4-8bdb-4f06-859a-ebe3d10b7e77",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.35,
        "x": 0.05,
        "y": 0.45
      },
      "kind": "list",
      "text": "AAV for Spinal muscular atrophy (SMA) / Zolgensma; AAV for hereditary retinal dystrophy / Luxturna",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "87636b9e-86d0-4213-95db-ef3cadaf960f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.35,
        "x": 0.05,
        "y": 0.25
      },
      "kind": "paragraph",
      "text": "Gene therapy: AAV Modifies genes directly in the patient with viral vector delivering therapeutic gene of interest",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07f9e0df-7c7c-4b1f-86d8-ea683399e26d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.3,
        "x": 0.05,
        "y": 0.07
      },
      "kind": "title",
      "text": "What is gene therapy?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a810cd5b-00cd-4a7f-a732-8533b17ab5b7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 80,
      "from": 45,
      "beatId": "0e318181-28dc-401d-b762-c3ba1b0a4abe",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document presents Berkeley Lights' technology and growth strategy as a solution to the presented problems",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 59,
      "from": 51,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "5881ba67-4f39-4100-b1e0-beb09a566b20",
      "evidence": "The document presents the potential benefits of Berkeley Lights' technology in reducing costs and improving efficiency",
      "position": 0,
      "objective": "Highlight the cost of inaction in gene therapy manufacturing",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}